Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Health Daily.
April 2025
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | 6 | |
| 7 | 8 | 9 | 10 | 11 | 12 | 13 |
| 14 | 15 | 16 | 17 | 18 | 19 | 20 |
| 21 | 22 | 23 | 24 | 25 | 26 | 27 |
| 28 | 29 | 30 |
May 2025
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | |||
| 5 | 6 | 7 | 8 | 9 | 10 | 11 |
| 12 | 13 | 14 | 15 | 16 | 17 | 18 |
| 19 | 20 | 21 | 22 | 23 | 24 | 25 |
| 26 | 27 | 28 | 29 | 30 | 31 |
June 2025
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
| 1 | ||||||
| 2 | 3 | 4 | 5 | 6 | 7 | 8 |
| 9 | 10 | 11 | 12 | 13 | 14 | 15 |
| 16 | 17 | 18 | 19 | 20 | 21 | 22 |
| 23 | 24 | 25 | 26 | 27 | 28 | 29 |
| 30 |
Press releases published on April 1, 2025
Inc. Names Health Advocates Network to Its 2025 List of the Fastest-Growing Private Companies in the Southeast
EIN Presswire
·
April 1, 2025
Companies on the Inc. Regionals: Southeast list had a median growth rate of 114 percent. BOCA RATON, FL, UNITED STATES, April 1, 2025 /EINPresswire.com/ -- Inc., the leading media brand and playbook for the entrepreneurs and business leaders shaping our …
OCOM Hosts Inaugural Research Symposium to Showcase Student Innovation in Medical Science
EIN Presswire
·
April 1, 2025
OCOM is proud to host its Inaugural Research Symposium on April 4, 2025, celebrating the groundbreaking research and academic excellence of its students. WINTER GARDEN, FL, UNITED STATES, April 1, 2025 /EINPresswire.com/ -- The Orlando College of …
VRIZE Recognized Among the Fastest-Growing Companies in the Inc. Southeast Regionals
EIN Presswire
·
April 1, 2025
VRIZE Secures a Spot in the Southeast’s Top 192, Contributing to 11,493 Jobs and an $8.1B Economic Impact TAMPA, FL, UNITED STATES, April 1, 2025 /EINPresswire.com/ -- Inc. magazine today announced that VRIZE has been ranked No. 43 on its fifth annual …
Nanopharmaceutics Inc. Announces Initiation of Clinical Study of Triapine + Radiation for Glioblastoma or Astrocytoma
EIN Presswire
·
April 1, 2025
Initiation of Clinical Study Testing the Addition of an Anti-Cancer Drug, Triapine®, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma TRON Group Inc. (OTCMKTS:TGRP) ALACHUA, FL, UNITED STATES, April 1, 2025 /EINPresswire.com/ -- …
R3 Distribution Partners with Drug Intervention Institute and ONEbox® to Combat Opioid Crisis
EIN Presswire
·
April 1, 2025
ONEbox® products are designed to provide on-demand training needed to administer the life-saving overdose reversal drug, naloxone. ST. PETERSBURG, FL, UNITED STATES, April 1, 2025 /EINPresswire.com/ -- The Drug Intervention Institute, Inc, located in …
Healthy Workforce Institute Receives Certification as Women-Owned Small Business by U.S. Small Business Administration
EIN Presswire
·
April 1, 2025
Designation recognizes the Institute’s commitment to leadership, innovation, and cultural transformation in healthcare OLDSMAR, FL, UNITED STATES, April 1, 2025 /EINPresswire.com/ -- The Healthy Workforce Institute is proud to announce its official …
Portsmouth Square Completes Strategic Refinancing of Hilton San Francisco Financial District Hotel
GlobeNewswire
·
April 1, 2025
SAN FRANCISCO, CA, April 01, 2025 (GLOBE NEWSWIRE) -- Portsmouth Square, Inc. (OTC: PRSI) ("Portsmouth Square" or "the Company") today announced the successful refinancing of its flagship asset, the Hilton San Francisco Financial District Hotel. This …
PreVu Launches New Mobile App for Fast Photo-Taking and Instant Upload
EIN Presswire
·
April 1, 2025
Eliminate photography challenges with instant, AI-guided patient photo uploads FT. LAUDERDALE, FL, UNITED STATES, April 1, 2025 /EINPresswire.com/ -- PreVu Software, a leading provider of digital smile simulation technology for dental practices, is …
COSCIENS Biopharma Inc. Announces Receipt of Management Cease Trade Order
GlobeNewswire
·
April 1, 2025
TORONTO, ONTARIO, April 01, 2025 (GLOBE NEWSWIRE) -- COSCIENS Biopharma Inc. (NASDAQ: CSCI) (TSX: CSCI) (“COSCIENS” or the “Company”), a life science company which develops and commercializes a diversified portfolio of cosmeceutical, nutraceutical and …
CDC Layoffs Deliver Devastating Blow to Respiratory Health
GlobeNewswire
·
April 1, 2025
Washington, DC, April 01, 2025 (GLOBE NEWSWIRE) -- The Asthma and Allergy Foundation of America (AAFA) is deeply concerned about recent reductions in force (RIFs) at the Centers for Disease Control and Prevention (CDC), which put critical public health …
Florida Mesothelioma Victims Center Urges a Person Who Had Workplace Exposure to Asbestos in a State Outside of Florida and Now Has Mesothelioma or Lung Cancer to Call the Gori Law Firm-Expect Better Compensation
EIN Presswire
·
April 1, 2025
ORLANDO , FL, UNITED STATES, April 1, 2025 /EINPresswire.com/ -- The Florida Mesothelioma Victims Center is urging the family of an individual who has just discovered they have mesothelioma or lung cancer to please call the Gori Law Firm at 866-532-2106 …
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
April 1, 2025
SAN DIEGO, April 01, 2025 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company developing a potentially first-in-class and best-in-class WEE1 inhibitor for patients with ovarian cancer and other …
Inventiva announces completion of enrollment in the Phase 3 NATiV3 clinical trial of lanifibranor in patients with MASH and advanced fibrosis
GlobeNewswire
·
April 1, 2025
Target enrollment exceeded with 1009 patients randomized in the main cohort and 410 patients in the exploratory cohort Topline results from NATiV3 projected in the second half of 2026 and, if positive, expected to be the basis for submission for regulatory …
Inventiva annonce la fin du recrutement de l’étude clinique de Phase 3 NATiV3 évaluant lanifibranor chez les patients atteints de MASH et de fibrose avancée
GlobeNewswire
·
April 1, 2025
Objectifs de recrutement dépassés avec 1.009 patients randomisés dans la cohorte principale et 411 dans la cohorte exploratoire Principaux résultats de NATiV3 attendus au deuxième semestre 2026 et, si positifs, ils supporteront les demandes règlementaires …
Cidara Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
GlobeNewswire
·
April 1, 2025
SAN DIEGO, April 01, 2025 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) immunotherapies, today announced that the Compensation and Human …
Pennant Expands Portfolio with Acquisition of Senior Living Community in Arizona
GlobeNewswire
·
April 1, 2025
EAGLE, Idaho, April 01, 2025 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice, home care and senior living companies, announces the acquisition of the real estate and …
BioStem Technologies Announces Extension to File 2024 Annual Report with OTC
GlobeNewswire
·
April 1, 2025
POMPANO BEACH, Fla., April 01, 2025 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC: BSEM), a leading MedTech company specializing in the development, manufacturing, and commercialization of placental-derived products for advanced wound care, announces …
Venus Concept Announces $11 million Debt-to-Equity Exchange Transaction
GlobeNewswire
·
April 1, 2025
TORONTO, April 01, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that, on March 31, 2025, the Company exchanged $11.0 million of its subordinated …
HCW Biologics Announces 1-for-40 Reverse Stock Split
GlobeNewswire
·
April 1, 2025
MIRAMAR, Fla., April 01, 2025 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the “Company” or “HCW Biologics”) (NASDAQ: HCWB), a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen health span by …
Respilean Review (BREAKING NEWS): Why Thousands Are Calling It the Natural Lung Breakthrough of 2025
GlobeNewswire
·
April 1, 2025
DENVER, April 01, 2025 (GLOBE NEWSWIRE) -- In a world where we measure everything—from step counts to calories—there’s one thing we rarely track until it’s already compromised: our lung health. With pollution rising, allergens becoming more aggressive, and …